Workflow
员工持股计划
icon
Search documents
博汇纸业: 2025年第一次临时股东大会会议资料
Zheng Quan Zhi Xing· 2025-08-22 16:24
三、现场会议地点:公司办公楼第三会议室 四、会议的表决方式:采取现场投票和网络投票相结合的方式 山东博汇纸业股份有限公司 山东博汇纸业股份有限公司 一、会议召开时间: 现场会议时间:2025 年 9 月 1 日 9:00 网络投票方式及时间:本次股东大会采用上海证券交易所网络投票系统,通 过交易系统投票平台的投票时间为 2025 年 9 月 1 日 9:15-9:25、9:30-11:30、 二、股权登记日:2025 年 8 月 25 日 号 A 股股东 非累积投票议案 宜的议案》 议案名称 序 投票股东类型 五、会议主持人:公司董事长 六、会议议程: 持有表决权的股份总数、列席人员; 宜的议案》 山东博汇纸业股份有限公司董事会 二○二五年八月二十三日 议案之一: 关于公司《领航者员工持股计划(草案)》及其摘要的议案 各位股东: 山东博汇纸业股份有限公司(以下简称"公司")《关于公司 <领航者员工持> 股计划(草案)>及其摘要的议案》已经公司 2025 年第一次临时董事会审议通过, 并于 2025 年 8 月 16 日刊登于上海证券交易所网站(http://www.sse.com.cn)。 请各位股东予以审议 ...
聚光科技:拟以1亿元-1.5亿元回购公司股份
Xin Lang Cai Jing· 2025-08-20 10:29
聚光科技公告,拟以1亿元-1.5亿元回购公司股份,回购价格不超过29.5元/股。预计回购股份数量约为 338.98万股-508.47万股,占公司总股本的0.76%-1.13%。回购股份将在未来适宜时机用于实施股权激励 计划或员工持股计划。 ...
万安科技: 董事会关于公司2025年员工持股计划草案的合规性说明
Zheng Quan Zhi Xing· 2025-08-13 10:13
浙江万安科技股份有限公司董事会 四、本次员工持股计划拟定的持有人均符合《指导意见》《自律监管指引第 规定的持有人范围,其作为公司本次员工持股计划持有人的主体资格合法、有效; 五、公司不存在向持有人提供贷款、贷款担保或任何其他财务资助的计划或 安排。公司实施本次员工持股计划可以建立和完善员工、股东的利益共享机制, 提高职工的凝聚力和公司竞争力,使经营者和股东成为利益共同体,提高管理效 率和经营者的积极性、责任心,有利于公司的持续发展和战略实现。 综上所述,董事会认为公司实施本次员工持股计划符合《指导意见》《自律 监管指引第 1 号》等相关规定,同意公司实施本次员工持股计划并提交公司股东 会审议。 关联董事在董事会审议本次员工持股计划相关事项时已回避表决。 特此说明。 浙江万安科技股份有限公司董事会 关于公司 2025 年员工持股计划草案合规性说明 浙江万安科技股份有限公司(以下简称"公司")根据《公司法》《证券法》 《关于上市公司实施员工持股计划试点的指导意见》(以下简称《指导意见》) 《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》 (以下简称《自律监管指引第 1 号》)等法律法规、规 ...
诚意药业: 上海市锦天城律师事务所关于浙江诚意药业股份有限公司2025年员工持股计划的法律意见书
Zheng Quan Zhi Xing· 2025-08-10 09:13
Core Viewpoint - Zhejiang Chengyi Pharmaceutical Co., Ltd. is implementing an employee stock ownership plan (ESOP) to enhance employee motivation and align their interests with shareholders, while ensuring compliance with relevant laws and regulations [1][11]. Group 1: Company Qualifications - Chengyi Pharmaceutical is a legally established and compliant public company, having obtained its business license on May 7, 2013 [3]. - The company has received approval from the China Securities Regulatory Commission for its initial public offering, confirming its legal status [3]. Group 2: Legality and Compliance of the ESOP - The ESOP was approved by the company's board on July 13, 2025, and is designed to last until its expiration or can be extended upon approval [4][8]. - The plan allows for a maximum of 228 participants, including management and key personnel, without any financial assistance from the company [4][5]. - The shares for the ESOP will be sourced from the company's repurchased A-shares, with a total expenditure of approximately RMB 76.4 million at a price of RMB 7.25 per share [5][10]. Group 3: Legal Procedures and Disclosure - The company has conducted necessary legal procedures, including a staff representative meeting and board approvals, in accordance with regulatory requirements [11][12]. - The company has disclosed relevant information regarding the ESOP in compliance with the guidelines set by the China Securities Regulatory Commission [16]. Group 4: Management and Governance - The ESOP will be managed by a committee elected by the participants, ensuring independent operation from the company's controlling shareholders and management [14][15]. - The plan includes provisions for avoiding conflicts of interest and ensuring that participants retain their rights as shareholders [15]. Group 5: Future Steps - The ESOP is pending approval from the shareholders' meeting, which is the final step in the implementation process [13][16].
科瑞技术(002957.SZ)拟推2025年员工持股计划 筹资总额不超1360.67万元
智通财经网· 2025-08-08 15:07
智通财经APP讯,科瑞技术(002957.SZ)披露2025年员工持股计划(草案),公司员工持股计划的参加对象 共计不超过42人,筹集资金总额不超过1360.67万元。股票来源为公司通过回购专用证券账户自二级市 场以集中竞价交易方式回购的A股普通股,员工持股计划将通过非交易过户等法律法规许可的方式,以 8.42元/股的价格购买公司回购的股份共计不超过161.6万股。 本员工持股计划的存续期不超过48个月,自公司股东大会审议通过本员工持股计划且公司公告最后一笔 公司股票过户至本员工持股计划名下之日起计算。 ...
顺络电子: 董事会薪酬与考核委员会关于公司第五期员工持股计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-07-30 16:45
Group 1 - The core viewpoint of the article is that Shenzhen Sunlord Electronics Co., Ltd. is implementing its fifth employee stock ownership plan, which aims to enhance corporate governance and attract talent while ensuring the interests of all shareholders, especially minority shareholders, are protected [1][2]. Group 2 - The employee stock ownership plan complies with relevant laws and regulations, ensuring that the eligibility of participants is legitimate and valid [2]. - The plan is designed to motivate employees, retain key management and business personnel, and align the interests of the company with those of its employees, promoting long-term and sustainable development [2]. - The board's compensation and assessment committee believes that the implementation of this plan will not harm the interests of the company or its shareholders, aligning with the company's long-term development needs [2].
柘中股份: 上海柘中集团股份有限公司第一期员工持股计划管理办法
Zheng Quan Zhi Xing· 2025-07-18 16:25
Core Points - The company has established the first employee stock ownership plan (ESOP) to align the interests of employees, shareholders, and the company for long-term development [1][2][3] - The total amount of funds to be raised under the ESOP is capped at 73.127125 million yuan, with each share priced at 1.00 yuan [4][5] - The plan allows for a maximum of 100 participants, including supervisors and core employees, while excluding major shareholders and their immediate family [3][4] Group 1: Objectives and Principles - The ESOP aims to enhance the governance structure and motivate employees, ensuring the company's stable long-term growth [2][3] - The plan adheres to principles of legal compliance, voluntary participation, and risk-bearing by participants [2][3] Group 2: Fundraising and Share Distribution - The funds for the ESOP will come from employees' legal salaries and self-raised funds, with no financial assistance from the company [5][6] - The share distribution includes 125,000 shares for each of the three supervisors and 6,937,712.5 shares for other designated personnel, totaling 7,312,712.5 shares [4][5] Group 3: Stock Source and Scale - The stocks for the ESOP will be sourced from the company's repurchased A-shares, with a maximum holding scale of 5,850,170 shares, representing 1.32% of the total share capital [6][7] - The company has previously repurchased 22,100,110 shares for a total transaction amount of approximately 241.48 million yuan [6] Group 4: Lock-up and Performance Assessment - The ESOP shares will be unlocked in three phases over 36 months, with specific percentages released at each interval [8][9] - Performance assessments will occur annually from 2025 to 2027, with specific profit targets set for each year to determine share unlock eligibility [10][11] Group 5: Management and Governance - The ESOP will be managed by a committee elected by the participants, with the company board overseeing the plan [11][12] - The board is authorized to handle all matters related to the ESOP, including adjustments and terminations [17][18] Group 6: Rights and Obligations of Participants - Participants have rights to dividends and other benefits proportional to their shareholdings, but cannot transfer or use their shares as collateral during the lock-up period [20][21] - In case of resignation or contract termination, the management committee will decide on the handling of the participant's shares [22][23]
信测标准: 董事会薪酬与考核委员会关于公司2025年员工持股计划相关事项的核查意见
Zheng Quan Zhi Xing· 2025-07-15 12:16
Group 1 - The company has the qualifications to implement the 2025 employee stock ownership plan, complying with relevant regulations and guidelines [1][2] - The employee stock ownership plan is designed to enhance employee cohesion and company competitiveness, motivating employees and retaining key talents for sustainable development [1][2] - The plan does not involve any forced participation or harm to the interests of the company and all shareholders [1][2] Group 2 - The board's compensation and assessment committee believes that the implementation of the employee stock ownership plan aligns with the long-term development needs of the company [2] - There are no circumstances that would harm the interests of the company or all shareholders in the execution of this plan [2]
诚意药业: 浙江诚意药业股份有限公司2025年员工持股计划管理办法
Zheng Quan Zhi Xing· 2025-07-13 08:12
Core Points - The article outlines the management measures for the 2025 Employee Stock Ownership Plan (ESOP) of Zhejiang Chengyi Pharmaceutical Co., Ltd. [1] - The ESOP aims to enhance employee motivation and align their interests with those of shareholders through stock ownership [9][10] Group 1: Basic Principles of the ESOP - The ESOP will be implemented in compliance with relevant laws and regulations, ensuring accurate and timely information disclosure [2] - Participation in the ESOP is voluntary, with no forced allocation to employees [2] - Participants bear their own risks and profits, ensuring equal rights with other investors [2] Group 2: Procedures for Implementing the ESOP - The Board of Directors is responsible for drafting the ESOP proposal [3] - Employee opinions will be solicited through representative meetings before the ESOP is implemented [3] - The proposal must be approved by a majority of non-related directors, and related directors must abstain from voting [3][4] Group 3: Funding and Stock Sources - The total funding for the ESOP will not exceed 48.286356 million yuan, with each share priced at 1.00 yuan [6] - The stock for the ESOP will be sourced from shares repurchased by the company [7] - The company plans to repurchase shares using between 50 million and 100 million yuan for the ESOP [7] Group 4: Stock Purchase Price and Determination - The purchase price for the stock will be set at 5.02 yuan per share, not lower than 50% of the average trading price over the previous trading days [8][9] - The pricing aims to promote long-term development and align employee interests with shareholder interests [9] Group 5: Lock-up Period and Performance Assessment - The lock-up period for the ESOP will last for 12 months, with shares released in three phases based on performance assessments [10][11] - Performance targets for the assessment years 2025-2027 include specific revenue growth percentages [13][14] Group 6: Management of the ESOP - The ESOP will be managed by a management committee elected by the participants [19] - The committee will oversee daily management and ensure the protection of participants' rights [19] - The management committee is responsible for handling the assets of the ESOP and making decisions regarding stock sales and distributions [23] Group 7: Rights and Obligations of Participants - Participants have the right to the economic benefits of the shares but waive certain shareholder rights [27] - Participants must comply with the management committee's decisions regarding their shares and any related obligations [27][28] Group 8: Liquidation and Distribution of the ESOP - Upon termination of the ESOP, the management committee will complete liquidation within 30 working days and distribute assets according to participants' shares [29] - The distribution will occur after deducting relevant taxes and fees [29]
安科生物: 安徽安科生物工程(集团)股份有限公司第4期员工持股计划管理办法
Zheng Quan Zhi Xing· 2025-07-10 16:21
Core Viewpoint - The company has established the 4th Employee Stock Ownership Plan (ESOP) to enhance employee engagement, attract talent, and align the interests of employees, shareholders, and the company for long-term development [1][2][3]. Summary by Sections General Principles - The ESOP aims to motivate participants, create a shared interest between employees and shareholders, and improve corporate governance [2][3]. - The plan adheres to legal compliance, voluntary participation, risk-bearing by participants, and selective involvement of employees [2][3]. Plan Structure - The total number of shares under the ESOP is capped at 2.894406 million shares, representing 1% of the company's total shares for any single participant [4][5]. - The plan is limited to key personnel in the oncology division, excluding directors, supervisors, and senior management [4][5]. Funding and Stock Source - Funding for the ESOP comes from employees' legal salaries and self-raised funds, with no financial assistance from the company [5][6]. - Shares for the ESOP will be sourced from the company's repurchased shares, with a maximum of 2.894406 million shares available for transfer [5][6]. Pricing and Incentives - The purchase price for the shares is set at 4.38 yuan per share, based on a calculated method considering market conditions [7][8]. - The pricing strategy aims to encourage employee participation while ensuring alignment with company performance and shareholder interests [7][8]. Duration and Lock-up Period - The ESOP has a duration of 72 months, with a lock-up period of 12 months before shares can be gradually unlocked [8][9]. - The unlocking schedule allows for 20% of shares to be released at specified intervals, promoting long-term commitment from participants [8][9]. Management and Governance - The ESOP is managed by a committee elected by participants, ensuring that the interests of all stakeholders are represented [12][15]. - The board of directors is responsible for drafting and modifying the ESOP, with oversight from the supervisory board [12][15]. Rights and Obligations of Participants - Participants must pay their subscription fees on time and are subject to performance evaluations that affect their share unlocks [13][19]. - Participants are prohibited from transferring or using their shares as collateral without committee approval [19][20]. Distribution of Benefits - Cash dividends received during the lock-up period will be retained within the ESOP and distributed proportionally after the lock-up ends [23][24]. - Upon the expiration of the ESOP, a final settlement will be conducted within 30 working days, distributing shares based on participants' holdings [24][26].